Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep89 | Adrenal medulla | ECE2017

Should all patients with Neurofibromatosis type 1 undergo biochemical screening for Pheocromocytoma?

Al-Sharefi Ahmed , Ashraff Suhel , Vanka Ramesh , Nag Satyajit

Pheocromocytomas (PHEO) are catecholamine secreting tumours which can occur sporadically or as part of other hereditary/familial syndromes including Neurofibromotosis 1 (NF-1). Unlike the case with other genetic syndromes, the current neurofibromatosis guidelines do not recommend a routine hormonal screening strategy for PHEO in the absence of hypertension or other symptoms. In this paper we describe 2 asymptomatic and normotensive patients with NF-1 where secretory PHEO were ...

ea0094p335 | Bone and Calcium | SFEBES2023

Iatrogenic hypercalcaemia in a patient with duchenne muscular dystrophy: a case report highlighting multifactorial aetiology and therapeutic considerations

C. Shekar Nitin , Vanka Ramesh , Jajah Bilal , khan Irfan , Awadelkareem Abuzar , Thanda Hnin

Background: Duchenne muscular dystrophy (DMD) is a progressive muscle disorder characterised by muscle wasting and weakness. It is often associated with intracellular hypercalcaemia in dystrophin deficient muscle leading to disease progression. We present a comprehensive case report of extracellular hypercalcaemia in a DMD patient, a rare complication, emphasising the interplay of iatrogenic factors, immobilisation, and therapeutic approaches.<p class="abs...